SPAC Update – January 10

– EMLD entered into a non-binding letter of intent with an unnamed target
– IBLUU pulled its S-1
– DECA stockholders approved Longevity Biomedical deal, 4.4 million shares (97.9%) redeemed, 98k shares remain
– LGST filed 424b3 for Tevogen Bio deal, vote Jan 29, NAV $11.07
– APTM filed DEF14a to extend deadline to Jan 30 2025, vote Jan 29, NAV $10.69
– CSTA filed DEF14a to extend deadline to Jan 29 2025, vote Jan 23, NAV $11.11
– ARIZ filed PRE14a to extend deadline to Nov 22 2024, vote in Feb
– NOVV extended deadline to Feb 10 2024, added $70k to trust account
– GLLI extended deadline to Feb 9 2024, added $60k to trust account
– ARRW extended deadline to Feb 4 2024, added $160k to trust account
– LBBB extended deadline to Feb 11 2024, added $20k to trust account
– ATEK extended deadline to Feb 14 2024, added $60k to trust account
– SVII extension vote
– ALSA extension vote
– HCVI extension vote
– TCOA redemption